ALLIANCE PHARMACEUTICAL CORP
S-4, EX-23.1, 2000-11-09
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ALLIANCE PHARMACEUTICAL CORP, S-4, EX-9.1, 2000-11-09
Next: ALLIANCE PHARMACEUTICAL CORP, S-4, EX-23.2, 2000-11-09



<PAGE>

                                                                    Exhibit 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-4) and related prospectus of Alliance
Pharmaceutical Corp. for the registration of 770,000 shares of its common stock
and to the incorporation by reference therein of our report dated August 1,
2000, with respect to the consolidated financial statements of Alliance
Pharmaceutical Corp. included in its Annual Report (Form 10-K) for the year
ended June 30, 2000, filed with the Securities and Exchange Commission.

                                               ERNST & YOUNG LLP

San Diego, California
November 3, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission